Transcatheter aortic valve replacement (TAVR) has replaced surgical aortic valve
replacement as the new gold standard in elderly patients with severe aortic valve stenosis …

Since the first groundbreaking procedure in 2002, transcatheter aortic valve implantation
(TAVI) has revolutionized the management of aortic stenosis (AS). Through striking …

Aims Transcatheter aortic valve implantation (TAVI) has emerged as established treatment
option in patients with symptomatic aortic stenosis. Technical developments in valve design …

Background: Few randomized trials have compared bioprostheses for transcatheter aortic
valve replacement, and no trials have compared bioprostheses with supra-annular design …

Background The postoperative outcomes of transcatheter aortic valve replacement (TAVR)
with the new generation of self-expanding valves (SEV) and balloon-expandable valves …

Objectives The aim of this study was to compare outcomes after transcatheter aortic valve
replacement (TAVR) with the SAPIEN 3 Ultra (Ultra) and SAPIEN 3 (S3) transcatheter heart …

Within the last two decades, transcatheter aortic valve replacement (TAVR) has
revolutionized the management of symptomatic severe aortic stenosis (AS). Newer …

Background Transcatheter aortic valve implantation (TAVI) has become standard treatment
for elderly patients with symptomatic severe aortic valve stenosis. The ACURATE neo AS …

Background Transcatheter aortic valve replacement (TAVR) with the ACURATE neo device
has been associated with a non-negligible incidence of paravalvular aortic regurgitation …

Aortic stenosis is the most common valvular disease requiring valve replacement. Valve
replacement therapies have undergone progressive evolution since the 1960s. Over the last …